SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 183.68 |
Enterprise Value ($M) | 18.34 |
Book Value ($M) | 222.54 |
Book Value / Share | 1.15 |
Price / Book | 0.83 |
NCAV ($M) | -144.00 |
NCAV / Share | -0.75 |
Price / NCAV | -1.28 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.17 |
Return on Assets (ROA) | -0.13 |
Return on Equity (ROE) | -0.26 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.42 |
Current Ratio | 1.55 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 247.08 |
Assets | 613.61 |
Liabilities | 391.07 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | State Street Corp | 1.80 | -75.28 | |
13G | Alyeska Investment Group, L.P. | 6.32 | ||
13G/A | PFM Health Sciences, LP | 1.90 | ||
13G | Granahan Investment Management Inc/ma | 7.38 | ||
13G/A | Tang Capital Partners Lp | 0.90 | -63.33 | |
13G/A | Vanguard Group Inc | 4.61 | 105.69 | |
13G | Goldman Sachs Group Inc | 6.40 | ||
13G/A | BlackRock Inc. | 4.70 | 21.93 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
3,560,139 | 8,178,424 | 43.53 | |
3,409,279 | 955,369 | 356.85 | |
3,725,783 | 8,694,759 | 42.85 | |
2,377,742 | 5,915,085 | 40.20 | |
2,795,711 | 7,851,762 | 35.61 | |
(click for more detail) |
Similar Companies | |
---|---|
BDTX – Black Diamond Therapeutics, Inc. | BEAM – Beam Therapeutics Inc. |
BIIB – Biogen Inc. | BMEA – Biomea Fusion, Inc. |
BMRN – BioMarin Pharmaceutical Inc. |
Financial data and stock pages provided by
Fintel.io